文献速递系统性红斑狼疮

系统性红斑狼疮患者单核细胞Siglec-14表达上调且与疾病活动度相关

Monocyte Siglec-14 expression is upregulated in patients with systemic lupus erythematosus and correlates with lupus disease activity.
PubMed 文献 · Rheumatology (Oxford) · 2017-01-01

该研究采用流式细胞术分析39例SLE患者外周血髓系细胞表面Siglec-5/14、Siglec-9和Siglec-10的表达,并对Siglec-5/14位点进行基因分型。结果显示SLE患者单核细胞Siglec-14表达显著高于健康对照,且与SLEDAI评分、抗Sm和抗SSB自身抗体正相关,与血清C3浓度负相关。

要点

  • SLE患者单核细胞Siglec-14表达显著高于健康对照(P<0.05)。
  • Siglec-14表达与SLEDAI评分、抗Sm和抗SSB抗体正相关(P<0.05)。
  • Siglec-14表达与血清C3浓度负相关(P<0.005)。

核心结论

  • Siglec免疫调节分子特别是单核细胞Siglec-14表达可能在SLE炎症事件中发挥重要作用。
  • 患者组与健康对照组之间SIGLEC14基因型分布未见偏倚。

研究设计与样本

  • 研究纳入39例SLE患者,采用流式细胞术分析外周血髓系细胞亚群表面Siglec-5/14、Siglec-9和Siglec-10表达。
  • 对Siglec-5/14位点进行基因分型,并评估SLEDAI、血清补体浓度和血清自身抗体等临床活动度标志物与Siglec水平的相关性。

主要发现

  • SLE患者单核细胞Siglec-14表达(中位数=518,四分位距:411)显著高于健康对照(中位数=427,四分位距:289.3;P<0.05)。
  • Siglec-14表达与SLEDAI评分、抗Sm和抗SSB自身抗体呈正相关(P<0.05)。
  • Siglec-14表达与患者血清C3浓度呈负相关(P<0.005)。
  • Siglec-5/14位点基因分型显示两组中Siglec-14无效等位基因频率均较高,反映亚洲人群中的发生率。

临床怎么用

  • 单核细胞Siglec-14表达可能与SLE疾病活动度相关,可作为潜在炎症标志物进一步研究。
  • Siglec-14与补体C3及自身抗体的相关性提示其在SLE炎症通路中可能发挥作用。

局限性

  • 研究样本量为39例SLE患者,样本量有限。
  • 作者指出需要进行更大规模混合 ethnicity 比较以揭示Siglecs在自身免疫病发病机制中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Siglecs are sialic acid-binding immunoglobulin-like lectins expressed on the surface of immune cells, which participate in the discrimination of self and non-self. We investigated myeloid CD33-related Siglec expression in a cohort of patients with SLE. METHODS: Cell surface expression of Siglec-5/14, Siglec-9 and Siglec-10 on peripheral myeloid subsets were analysed from 39 SLE patients using flow cytometry. Genotyping of the Siglec-5/14 locus was also performed. Clinical markers of SLE disease activity, including SLEDAI, serum complement concentrations and serum autoantibodies, were assessed and correlated with Siglec levels. RESULTS: Siglec-14 expression on SLE monocytes (median = 518, interquartile range: 411) was significantly higher when compared with healthy controls (median = 427, interquartile range: 289.3; P < 0.05) and correlated positively with SLEDAI scoring and anti-Sm and anti-SSB autoantibodies (P < 0.05). A negative correlation was determined with patient serum C3 concentrations (P < 0.005). Genotyping of the Siglec-5/14 locus revealed a high frequency of the Siglec-14 null allele across both groups, reflecting the incidence in Asian populations. CONCLUSION: Our data suggest that the Siglec immunomodulatory molecules, in particular Siglec-14 expression on monocytes, may play an important role in the inflammatory events of SLE. No bias was found with regard to SIGLEC14 genotype in our patient group compared with healthy controls. Larger comparisons of mixed ethnicity might, however, reveal an important role for Siglecs in the pathogenesis of autoimmune disease.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Thornhill SI, Mak A, Lee B, et al. Monocyte Siglec-14 expression is upregulated in patients with systemic lupus erythematosus and correlates with lupus disease activity. Rheumatology (Oxford). 2017. PMID: 28137763. doi:10.1093/rheumatology/kew498

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。